PURPOSE: T-Cell lymphomas constitute heterogeneous and aggressive tumors in which pathogenic alterations remain largely unknown. Expression profiling has demonstrated to be a useful tool for molecular classification of tumors. EXPERIMENTAL DESIGN: Using DNA microarrays (CNIO-OncoChip) containing 6386 cancer-related genes, we established the expression profiling of T-cell lymphomas and compared them to normal lymphocytes and lymph nodes. RESULTS: We found significant differences between the peripheral and lymphoblastic T-cell lymphomas, which include a deregulation of nuclear factor-kappaB signaling pathway. We also identify differentially expressed genes between peripheral T-cell lymphoma tumors and normal T lymphocytes or reactive lymph nodes, which could represent candidate tumor markers of these lymphomas. Additionally, a close relationship between genes associated to survival and those that differentiate among the stages of disease and responses to therapy was found. CONCLUSIONS: Our results reflect the value of gene expression profiling to gain insight about the molecular alterations involved in the pathogenesis of T-cell lymphomas.
PURPOSE:T-Cell lymphomas constitute heterogeneous and aggressive tumors in which pathogenic alterations remain largely unknown. Expression profiling has demonstrated to be a useful tool for molecular classification of tumors. EXPERIMENTAL DESIGN: Using DNA microarrays (CNIO-OncoChip) containing 6386 cancer-related genes, we established the expression profiling of T-cell lymphomas and compared them to normal lymphocytes and lymph nodes. RESULTS: We found significant differences between the peripheral and lymphoblastic T-cell lymphomas, which include a deregulation of nuclear factor-kappaB signaling pathway. We also identify differentially expressed genes between peripheral T-cell lymphoma tumors and normal T lymphocytes or reactive lymph nodes, which could represent candidate tumor markers of these lymphomas. Additionally, a close relationship between genes associated to survival and those that differentiate among the stages of disease and responses to therapy was found. CONCLUSIONS: Our results reflect the value of gene expression profiling to gain insight about the molecular alterations involved in the pathogenesis of T-cell lymphomas.
Authors: Xi Wang; Miriam B F Werneck; Boris G Wilson; Hye-Jung Kim; Michael J Kluk; Christopher S Thom; Jonathan W Wischhusen; Julia A Evans; Jonathan L Jesneck; Phuong Nguyen; Courtney G Sansam; Harvey Cantor; Charles W M Roberts Journal: J Clin Invest Date: 2011-09-19 Impact factor: 14.808
Authors: Jean L Koff; Dai Chihara; Anh Phan; Loretta J Nastoupil; Jessica N Williams; Christopher R Flowers Journal: Curr Hematol Malig Rep Date: 2015-09 Impact factor: 3.952
Authors: Nicola Potter; Aikaterini Karakoula; Kim P Phipps; William Harkness; Richard Hayward; Dominic N P Thompson; Thomas S Jacques; Brian Harding; David G T Thomas; Rodger W Palmer; Jeremy Rees; John Darling; Tracy J Warr Journal: Neoplasia Date: 2008-08 Impact factor: 5.715
Authors: Jose M Carvajal-Gonzalez; Sonia Mulero-Navarro; Angel Carlos Roman; Vincent Sauzeau; Jaime M Merino; Xose R Bustelo; Pedro M Fernandez-Salguero Journal: Mol Biol Cell Date: 2009-01-21 Impact factor: 4.138
Authors: Lindsay M Morton; Mark P Purdue; Tongzhang Zheng; Sophia S Wang; Bruce Armstrong; Yawei Zhang; Idan Menashe; Nilanjan Chatterjee; Scott Davis; Qing Lan; Claire M Vajdic; Richard K Severson; Theodore R Holford; Anne Kricker; James R Cerhan; Brian Leaderer; Andrew Grulich; Meredith Yeager; Wendy Cozen; Shelia Hoar Zahm; Stephen J Chanock; Nathaniel Rothman; Patricia Hartge Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-03-31 Impact factor: 4.254